论文信息 - Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19 - 字舞流文

Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19

Kei Irie | H. Ikesue | T. Hashida | K. Tomii | Shoji Fukushima | A. Nakagawa | Ryo Tamura | Nobuyuki Muroi | Masaaki Eto | Hirohito Muroi